Grifols and the European Investment Bank sign an Euros 85 million long-term loan to support its R+D+i initiatives
The European Investment Bank (EIB) and Grifols signed an Euros 85 million loan to support the company's R+D+i initiatives focused...
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™...
AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint
AstraZeneca has announced positive top-line results of the phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 µg, twice-daily),...
Sanofi’s BRIGHT study comparing Toujeo with insulin degludec meets primary objective
Sanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with...
CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
CSL Limited and Vitaeris Inc.announced that they have entered into a strategic collaboration and purchase option agreement to expedite the...
One reason clinical trials for Alzheimer’s disease have failed — And the digital biomarker that could help address that
Introducing a new disease-modifying therapy, from research through to launch, is an extremely complex process, with lengthy and expensive drug...
Shire and Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill™ technology for the oral delivery of factor therapy
Shire plc , the biotech leader in rare diseases, and Rani Therapeutics, an InCube Labs company, announced a collaboration to...
Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement...
Mylan and Aspen Announce Launch of Generic Busulfex® Injection
Mylan N.V. and its partner, Aspen announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose...
Eone-Diagnomics Genome Center developed the world’s first non-invasive prenatal test algorithms using AI technology
Eone-Diagnomics Genome Center (EDGC), a Korean genetic analysis company, said today that it has started applying machine learning-based Artificial Intelligence...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.